BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7530387)

  • 1. Nitric oxide synthase inhibition and platelet function.
    Bodzenta-Lukaszyk A; Gabryelewicz A; Lukaszyk A; Bielawiec M; Konturek JW; Domschke W
    Thromb Res; 1994 Sep; 75(6):667-72. PubMed ID: 7530387
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological and pharmacological role of nitric oxide in platelet function.
    Radomski MW; Moncada S
    Adv Exp Med Biol; 1993; 344():251-64. PubMed ID: 7516113
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
    Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain.
    Das I; Khan NS; Puri BK; Sooranna SR; de Belleroche J; Hirsch SR
    Biochem Biophys Res Commun; 1995 Jul; 212(2):375-80. PubMed ID: 7542874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
    Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
    Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.
    Radomski MW; Jenkins DC; Holmes L; Moncada S
    Cancer Res; 1991 Nov; 51(22):6073-8. PubMed ID: 1718593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in autoimmunity.
    Vladutiu AO
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):1-11. PubMed ID: 7541734
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nitric oxide synthase inhibitors on gastric alkaline secretion in rats.
    Takeuchi K; Ohuchi T; Miyake H; Sugawara H; Okabe S
    Jpn J Pharmacol; 1992 Nov; 60(3):303-5. PubMed ID: 1283424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct electrochemical measurement of nitric oxide released from human platelets.
    Malinski T; Radomski MW; Taha Z; Moncada S
    Biochem Biophys Res Commun; 1993 Jul; 194(2):960-5. PubMed ID: 8343175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for altered platelet nitric oxide synthesis in essential hypertension.
    Cadwgan TM; Benjamin N
    J Hypertens; 1993 Apr; 11(4):417-20. PubMed ID: 8390509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection.
    Bastian NR; Xu S; Shao XL; Shelby J; Granger DL; Hibbs JB
    Biochim Biophys Acta; 1994 May; 1226(2):225-31. PubMed ID: 7515690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric mucosal nitric oxide synthase activity: inhibition by phosphorylation, arginine analogues and trifluoperazine.
    Williams JM; Brown JF; Hanson PJ; Whittle BJ
    Biochem Soc Trans; 1994 Aug; 22(3):271S. PubMed ID: 7529722
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of superoxide dismutase on nitric oxide production by RAW264 macrophages.
    Fricker SP; Slade E; Powell NA
    Biochem Soc Trans; 1995 May; 23(2):231S. PubMed ID: 7545607
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of nebivolol on human platelet aggregation.
    Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antioxidant properties of an inhibitor of nitric oxide synthase.
    Jessup W; Dean RT
    Free Radic Biol Med; 1993 Apr; 14(4):447-8. PubMed ID: 7682193
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis and actions of nitric oxide.
    Moncada S; Palmer RM
    Semin Perinatol; 1991 Feb; 15(1):16-9. PubMed ID: 2063225
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of nitric oxide synthase].
    Hattori R; Yui Y
    Nihon Rinsho; 1992 Feb; 50(2):311-4. PubMed ID: 1377292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.